
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-04-3006:44 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001558370-21-005321 |
| 2021-04-2806:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-004976 |
| 2021-03-3007:38 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-003681 |
| 2021-03-3007:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-003678 |
| 2021-02-2307:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-21-001407 |
| 2021-02-1606:21 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-022556 |
| 2020-12-3007:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-20-014567 |
| 2020-10-2907:26 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001558370-20-011974 |
| 2020-10-2907:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-20-011970 |
| 2020-10-2317:01 ET | 8-K/A | 5.07 Shareholder vote results | 0001558370-20-011697 |
| 2020-10-0117:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-20-111165 |
| 2020-09-0807:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-102834 |
| 2020-08-1106:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-092996 |
| 2020-08-1007:04 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001104659-20-092375 |
| 2020-08-1006:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-092367 |
| 2020-06-0817:04 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-20-070904 |
| 2020-06-0117:20 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-03-31 | 0001104659-20-068485 |
| 2020-06-0107:08 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001104659-20-067982 |
| 2020-06-0106:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-067973 |
| 2020-05-2806:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-066624 |
| 2020-05-1106:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-059085 |
| 2020-05-1106:06 ET | 8-K | 8.01 Other events | 0001104659-20-059038 |
| 2020-04-1516:30 ET | DEF 14A | Proxy statementPeriod 2020-06-07 | 0001104659-20-046926 |
| 2020-03-1816:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-035325 |
| 2020-03-1216:45 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001104659-20-032540 |
| 2020-03-1208:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-032178 |
| 2020-03-1208:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-032169 |
| 2020-02-1016:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-013512 |
| 2020-02-0606:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-011603 |
| 2019-12-2006:11 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-19-074602 |
| 2019-12-1907:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-19-074052 |
| 2019-12-0916:12 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-070966 |
| 2019-11-1806:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-064875 |
| 2019-11-0706:59 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001104659-19-060804 |
| 2019-11-0706:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-060801 |
| 2019-10-1708:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-054507 |
| 2019-10-1516:30 ET | DEF 14A | Proxy statementPeriod 2019-12-09 | 0001104659-19-054172 |
| 2019-09-2407:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-19-045689 |
| 2019-08-3016:15 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001144204-19-043024 |
| 2019-08-1316:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-19-039539 |
| 2019-08-0816:06 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001144204-19-038552 |
| 2019-08-0806:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-19-038367 |
| 2019-07-2907:09 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-19-036350 |
| 2019-07-2216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001144204-19-035361 |
| 2019-06-1707:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-19-031092 |
| 2019-06-0607:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-19-029957 |
| 2019-05-3107:00 ET | 8-K | 5.07 Shareholder vote results | 0001144204-19-029036 |
| 2019-05-2107:35 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-19-027423 |
| 2019-05-0616:06 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001144204-19-023895 |
| 2019-05-0607:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-19-023738 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.